Hayward Holdings, Inc. HAYW
5 trading plans running, 12 Form 144 notices for $19.5M
10-Q, 10-K and Form 144What HAYW's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Aug 9, 2024 to Jul 30, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Eifion Jones Senior Vice President, Chief Financial Officer |
Adopted 10b5-1 plan | Aug 13, 2026 | 10-Q Oct 28, 2026 | ||
What the company wroteOn August 13, 2026, Eifion Jones, our Senior Vice President, Chief Financial Officer, adopted a Rule 10b5-1 Trading Plan that provides for the exercise of stock options and the sale, subject to certain conditions (including limit prices), of up to 196,887 shares of our common stock acquired on those exercises. It also covers up to an additional 79,113 shares of our common stock acquired on the exercise of stock options. Sales may be made under this trading plan through April 14, 2027, for a duration of 245 days. | |||||
| Eric L. Sejourne Senior Vice President, Chief Global Operations Officer |
Adopted 10b5-1 plan | Aug 7, 2026 | 10-Q Oct 28, 2026 | ||
What the company wroteOn August 7, 2026, Eric L. Sejourne, our Senior Vice President, Chief Global Operations Officer, adopted a Rule 10b5-1 Trading Plan that provides for the sale, subject to certain conditions (including a limit price), of 100% of the net shares of our common stock (after tax withholding) issuable upon the vesting of 20,361 restricted stock units and 15,570 performance stock units (at target; the actual number of shares issuable upon the vesting may vary). Sales may be made under this trading plan through July 30, 2027, for a duration of 358 days. | |||||
| Kevin Holleran, President and Chief Executive Officer |
Adopted 10b5-1 plan | Aug 3, 2026 | 10-Q Oct 28, 2026 | ||
What the company wroteOn August 3, 2026, Kevin Holleran, our President and Chief Executive Officer, adopted a Rule 10b5-1 Trading Plan that provides for the sale, subject to certain conditions, of up to 332,000 shares of our common stock issuable upon the exercise of vested stock options and 8,000 shares held by certain trusts. Sales may be made under this trading plan through June 30, 2027, for a duration of 332 days. | |||||
| Susan M. Canning Senior Vice President, Chief Legal Officer and Corporate Secretary |
Adopted 10b5-1 plan | May 19, 2026 | 10-Q Jul 29, 2026 | ||
What the company wroteOn May 19, 2026, Susan M. Canning, our Senior Vice President, Chief Legal Officer and Corporate Secretary, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c). The trading plan provides for the sale, subject to certain conditions, of up to 27,500 shares of our common stock, together with 33.33% of the shares issuable upon the vesting or settlement of certain restricted stock unit and performance stock unit awards. Sales may be made under this trading plan through March 31, 2027, for a duration of 317 days. | |||||
| Kevin Holleran President and Chief Executive Officer |
Adopted 10b5-1 plan | Mar 10, 2026 | 10-Q Apr 29, 2026 | ||
What the company wroteOn March 10, 2026, Kevin Holleran, our President and Chief Executive Officer, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c) to sell, subject to certain conditions, up to 515,000 shares of our common stock. Sales may be made under this trading plan through December 31, 2026, for a duration of 297 days. | |||||
| Eifion Jones Senior Vice President and Chief Financial Officer |
Adopted 10b5-1 plan | Dec 8, 2025 | 10-K Feb 25, 2026 | ||
| Kevin Holleran President and Chief Executive Officer |
Adopted 10b5-1 plan | Aug 18, 2025 | 10-Q Oct 29, 2025 | ||
What the company wroteOn August 18, 2025, Kevin Holleran, a director and our President and Chief Executive Officer, entered into a Rule 10b5-1 Trading Plan that provides that Mr. Holleran, acting through a broker, may sell up to an aggregate of 514,335 shares of our common stock. Sales of shares under the plan may only occur from January 5, 2026 to June 30, 2026. The plan is scheduled to terminate on June 30, 2026, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. Holleran or the broker, or as otherwise provided in the plan. | |||||
| Eifion Jones Senior Vice President, Chief Financial Officer |
Adopted 10b5-1 plan | Mar 11, 2025 | 10-Q May 1, 2025 | ||
What the company wroteOn March 11, 2025, Eifion Jones, our Senior Vice President, Chief Financial Officer, entered into a Rule 10b5-1 Trading Plan that provides that Mr. Jones, acting through a broker, may sell up to an aggregate of 100,000 shares of our common stock. Sales of shares under the plan may only occur from June 10, 2025, to November 28, 2025. The plan is scheduled to terminate on November 28, 2025, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. Jones or the broker, or as otherwise provided in the plan. | |||||
| Kevin Holleran President and Chief Executive Officer |
Adopted 10b5-1 plan | Mar 11, 2025 | 10-Q May 1, 2025 | ||
What the company wroteOn March 11, 2025, Kevin Holleran, our President and Chief Executive Officer, entered into a Rule 10b5-1 Trading Plan that provides that Mr. Holleran, acting through a broker, may sell up to an aggregate of 624,000 shares of our common stock. Sales of shares under the plan may only occur from June 16, 2025, to December 12, 2025. The plan is scheduled to terminate on December 12, 2025, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. Holleran or the broker, or as otherwise provided in the plan. | |||||
| Eifion Jones Senior Vice President, Chief Financial Officer |
Adopted 10b5-1 plan | Aug 9, 2024 | 10-Q Oct 29, 2024 | ||
What the company wroteOn August 9, 2024, Eifion Jones, our Senior Vice President, Chief Financial Officer, entered into a Rule 10b5-1 Trading Plan that provides that Mr. Jones, acting through a broker, may sell up to an aggregate of 100,000 shares of our common stock. Sales of shares under the plan may only occur from November 8, 2024, to May 30, 2025. The plan is scheduled to terminate on May 30, 2025, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. Jones or the broker, or as otherwise provided in the plan. | |||||
| Kevin Holleran President and Chief Executive Officer |
Adopted 10b5-1 plan | Aug 9, 2024 | 10-Q Oct 29, 2024 | ||
What the company wroteOn August 9, 2024, Kevin Holleran, our President and Chief Executive Officer, entered into a Rule 10b5-1 Trading Plan that provides that Mr. Holleran, acting through a broker, may sell up to an aggregate of 600,000 shares of our common stock. Sales of shares under the plan may only occur from November 11, 2024, to June 13, 2025. The plan is scheduled to terminate on June 13, 2025, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. Holleran or the broker, or as otherwise provided in the plan. | |||||
| Susan M. Canning Senior Vice President, Chief Legal Officer |
Adopted 10b5-1 plan | Mar 13, 2024 | 10-Q May 2, 2024 | ||
| Rick Roetken President, North America |
Adopted 10b5-1 plan | May 17, 2023 | 10-Q Aug 2, 2023 | ||
What the company wroteOn May 17, 2023, Rick Roetken, our President, North America entered into a Rule 10b5-1 Trading Plan that provides that Mr. Roetken, acting through a broker, may exercise stock options and sell up to an aggregate of 1,004,208 shares of our common stock. Sales of shares under the plan may only occur from August 16, 2023 to January 31, 2024. The plan is scheduled to terminate on January 31, 2024, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. Roetken or the broker, or as otherwise provided in the plan. | |||||
| Fernando Blasco Vice President, General Manager, Europe & Rest of World |
Adopted 10b5-1 plan | May 16, 2023 | 10-Q Aug 2, 2023 | ||
What the company wroteMay 16, 2023, Fernando Blasco, our Vice President, General Manager, Europe & Rest of World, entered into a Rule 10b5-1 Trading Plan that provides that Mr. Blasco, acting through a broker, may exercise stock options and sell up to an aggregate of 29,250 shares of our common stock. Sales of shares under the plan may only occur from August 15, 2023 to December 29, 2023. The plan is scheduled to terminate on December 29, 2023, subject to earlier termination upon the sale of all shares subject to the plan, under termination by Mr. Blasco or the broker, or as otherwise provided in the plan. | |||||
| Eifion Jones Chief Financial Officer |
Adopted 10b5-1 plan | Mar 8, 2023 | 10-Q Aug 2, 2023 | ||
What the company wroteOn March 8, 2023, Eifion Jones, our Chief Financial Officer, entered into a Rule 10b5-1 Trading Plan that provides that Mr. Jones, acting through a broker, may exercise stock options and sell up to an aggregate of 235,000 shares of our common stock. Sales of shares under the plan may only occur from June 7, 2023 to November 30, 2023. The plan is scheduled to terminate on November 30, 2023, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. Jones or the broker, or as otherwise provided in the plan. | |||||
| Kevin Holleran President and Chief Executive Officer |
Adopted 10b5-1 plan | Mar 7, 2023 | 10-Q Aug 2, 2023 | ||
What the company wroteOn March 7, 2023, Kevin Holleran, our President and Chief Executive Officer, entered into a Rule 10b5-1 Trading Plan that provides that Mr. Holleran, acting through a broker, may sell up to an aggregate of 403,711 shares of our common stock. Sales of shares under the plan may only occur from June 6, 2023 to December 29, 2023. The plan is scheduled to terminate on December 29, 2023, subject to earlier termination upon the sale of all shares subject to the plan, upon termination by Mr. Holleran or the broker, or as otherwise provided in the plan. | |||||
| Kevin Holleran director and our President and Chief Executive Officer |
Adopted 10b5-1 plan | – | 10-K Feb 29, 2024 | ||
Show the other 9 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Nov 13, 2026 | Jones Eifion Officer |
40,000 | $673K |
| Nov 2, 2026 | Canning Susan M. Officer |
2,500 | $42K |
| Oct 30, 2026 | Canning Susan M. Officer |
2,500 | $40K |
| Oct 29, 2026 | Canning Susan M. Officer |
2,000 | $31K |
| Oct 15, 2026 | Canning Susan M. Officer |
3,500 | $41K |
| Oct 5, 2026 | Kevin Holleran Officer |
295,000 | $3.7M |
| Sep 15, 2026 | Canning Susan M. Officer |
3,500 | $45K |
| Aug 17, 2026 | Canning Susan M. Officer |
3,500 | $53K |
| Jul 1, 2026 | Kevin Holleran Officer |
220,000 | $3.7M |
| May 5, 2026 | Kevin Holleran Officer |
304,778 | $4.4M |
| Mar 9, 2026 | Jones Eifion Officer |
15,000 | $219K |
| Jan 5, 2026 | Kevin Holleran Officer |
409,557 | $6.5M |
Show the other 4 notices
From the Form 144 XML filed with the SEC, since Jan 5, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HAYW/export.csv") into a cell.